Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: September 4, 2026 at 11:55 PM UTC
| NCT Number | NCT07708961 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | September 2, 2026 (2 days ago) |
As of September 4, 2026: Clinical trial NCT07708961 is currently recruiting participants. This phase2 study for glioblastoma, idh-wildtype is actively seeking new participants at 3 locations across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07708961 is actively recruiting participants as of September 4, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07708961 was last updated 2 days ago (September 2, 2026). HelloStudys verifies this status automatically.